Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “inhibitor”

2,878 pharma patents match "inhibitor" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,878
Index total 30,257
Page 2 / 120

Quick answer

This filtered view shows 2,878 pharmaceutical patents matching "inhibitor" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,878 results for “inhibitor” · 30,257 patents in full index Clear search

  1. US 12414981

    JNK inhibitors for use in treating and preventing neurodegenerative disorders

    Northwestern University · Granted Sep 16, 2025 · Expires Sep 11, 2045

    granted
  2. US 12414953

    Selective inhibitors of protein arginine methyltransferase 5 (PRMT5)

    Prelude Therapeutics, Incorporated · Granted Sep 16, 2025 · Expires Sep 11, 2045

    granted
  3. US 12409225

    Ras inhibitors

    Revolution Medicines, Inc. · Granted Sep 9, 2025 · Expires Sep 4, 2045

    granted
  4. US 12410184

    Crystalline forms of a menin inhibitor

    Kura Oncology, Inc. · Granted Sep 9, 2025 · Expires Sep 4, 2045

    granted
  5. US 12403141

    Deuterated MK2 pathway inhibitors and methods of using the same

    Aclaris Therapeutics, Inc. · Granted Sep 2, 2025 · Expires Aug 28, 2045

    granted
  6. US 12403196

    Ras inhibitors

    Revolution Medicines, Inc. · Granted Sep 2, 2025 · Expires Aug 28, 2045

    granted
  7. US 12404243

    Inhibitors of the Wnt/beta-catenin pathway

    The Regents of the University of California · Granted Sep 2, 2025 · Expires Aug 28, 2045

    granted
  8. US 12403154

    Administration of sting agonist and checkpoint inhibitors

    Takeda Pharmaceutical Company Limited · Granted Sep 2, 2025 · Expires Aug 28, 2045

    granted
  9. US 12398154

    Azaquinazoline pan-KRas inhibitors

    Mirati Therapeutics, Inc. · Granted Aug 26, 2025 · Expires Aug 21, 2045

    granted
  10. US 12398131

    Thiadiazolyl derivatives as DNA polymerase theta inhibitors and uses thereof

    IDEAYA Biosciences, Inc. · Granted Aug 26, 2025 · Expires Aug 21, 2045

    granted
  11. US 12390473

    Methods of treating tyrosine kinase inhibitor-induced diarrhea

    The Regents of the University of California · Granted Aug 19, 2025 · Expires Aug 14, 2045

    granted
  12. US 12390453

    Method for reducing side effects from administration of phosphodiesterase-4 inhibitors

    ARCUTIS BIOTHERAPEUTICS, INC. · Granted Aug 19, 2025 · Expires Aug 14, 2045

    granted
  13. US 12390427

    Plasminogen activator inhibitor-1 (PAI-1) inhibitor and method of use

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Aug 19, 2025 · Expires Aug 14, 2045

    granted
  14. US 12391669

    Substituted pyrimidines as IRE1 kinase inhibitors

    The Regents of the University of California et al. · Granted Aug 19, 2025 · Expires Aug 14, 2045

    granted
  15. US 12391642

    Tetrahydro-1H-cyclopenta[cd]indene derivatives as hypoxia inducible factor-2(alpha) inhibitors

    NIKANG THERAPEUTICS, INC. · Granted Aug 19, 2025 · Expires Aug 14, 2045

    granted
  16. US 12384775

    Pyrimid-2-yl-pyrazole compounds as IRAK inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Aug 12, 2025 · Expires Aug 7, 2045

    granted
  17. US 12384753

    17-beta-hydroxysteroid dehydrogenase type 13 inhibitors and methods of use thereof

    Enanta Pharmaceuticals, Inc. · Granted Aug 12, 2025 · Expires Aug 7, 2045

    granted
  18. US 12383538

    Use of mTOR inhibitors for prevention of intestinal polyp growth and cancer

    The Board of Regents of the University of Texas System · Granted Aug 12, 2025 · Expires Aug 7, 2045

    granted
  19. US 12383582

    Methods of treating chronic wounds with amniotic fluid having elevated levels of tissue inhibitors of matrix metalloproteinases

    Prime Merger Sub, LLC · Granted Aug 12, 2025 · Expires Aug 7, 2045

    granted
  20. US 12383535

    Hydrogen peroxide-responsive KEAP1-NRF2 ppi inhibitor prodrug, and preparation method therefor

    CHINA PHARMACEUTICAL UNIVERSITY · Granted Aug 12, 2025 · Expires Aug 7, 2045

    granted
  21. US 12384750

    Ras inhibitors

    Revolution Medicines, Inc. · Granted Aug 12, 2025 · Expires Aug 7, 2045

    granted
  22. US 12384761

    Imidazolo indazole compounds as JAK inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Aug 12, 2025 · Expires Aug 7, 2045

    granted
  23. US 12378241

    Pyridine derivative as FGFR and VEGFR dual inhibitors

    CGeneTech (Suzhou, China) CO., Ltd. · Granted Aug 5, 2025 · Expires Jul 31, 2045

    granted
  24. US 12377078

    Viral inhibitors, the synthesis thereof, and intermediates thereto

    Takeda Pharmaceutical Company Limited · Granted Aug 5, 2025 · Expires Jul 31, 2045

    granted